CAMP4 Therapeutics Corporation (NASDAQ:CAMP) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of CAMP4 Therapeutics Corporation (NASDAQ:CAMP) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $8.60.

CAMP has been the topic of several research reports. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CAMP4 Therapeutics in a research note on Friday, March 6th. Leerink Partners upped their price target on CAMP4 Therapeutics from $8.00 to $9.00 and gave the company an “outperform” rating in a research note on Thursday, April 2nd. Weiss Ratings lowered CAMP4 Therapeutics from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, May 21st. Finally, Rodman & Renshaw initiated coverage on CAMP4 Therapeutics in a research note on Tuesday, April 14th. They set a “buy” rating and a $7.00 price target on the stock.

Hedge Funds Weigh In On CAMP4 Therapeutics

Several hedge funds have recently added to or reduced their stakes in the stock. Janus Henderson Group PLC lifted its stake in CAMP4 Therapeutics by 35.9% in the fourth quarter. Janus Henderson Group PLC now owns 6,307,636 shares of the Wireless communications provider’s stock valued at $38,807,000 after buying an additional 1,666,666 shares during the period. Vivo Capital LLC lifted its stake in CAMP4 Therapeutics by 8.3% in the fourth quarter. Vivo Capital LLC now owns 4,246,568 shares of the Wireless communications provider’s stock valued at $26,031,000 after buying an additional 325,000 shares during the period. Balyasny Asset Management L.P. acquired a new position in CAMP4 Therapeutics in the fourth quarter valued at about $14,938,000. Adage Capital Partners GP L.L.C. lifted its stake in CAMP4 Therapeutics by 11.3% in the fourth quarter. Adage Capital Partners GP L.L.C. now owns 2,181,679 shares of the Wireless communications provider’s stock valued at $13,374,000 after buying an additional 220,895 shares during the period. Finally, SummitTX Capital L.P. acquired a new position in CAMP4 Therapeutics in the first quarter valued at about $1,497,000.

CAMP4 Therapeutics Stock Performance

Shares of CAMP stock opened at $4.17 on Thursday. The stock’s fifty day moving average is $4.40 and its 200-day moving average is $4.67. The stock has a market capitalization of $216.55 million, a PE ratio of -1.77 and a beta of 0.08. CAMP4 Therapeutics has a 52 week low of $1.30 and a 52 week high of $7.75.

CAMP4 Therapeutics (NASDAQ:CAMP) last issued its quarterly earnings results on Thursday, May 7th. The Wireless communications provider reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.11). CAMP4 Therapeutics had a negative net margin of 2,193.72% and a negative return on equity of 194.74%. The firm had revenue of $1.29 million for the quarter. As a group, analysts forecast that CAMP4 Therapeutics will post -0.8 earnings per share for the current fiscal year.

CAMP4 Therapeutics Company Profile

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location.